Presidio Management Group Xii, L.l.c. - Net Worth and Insider Trading
Presidio Management Group Xii, L.l.c. Net Worth
The estimated net worth of Presidio Management Group Xii, L.l.c. is at least $13 Million dollars as of 2024-09-20. Presidio Management Group Xii, L.l.c. is the 10% Owner of Silverback Therapeutics Inc and owns about 2,221,798 shares of Silverback Therapeutics Inc (SBTX) stock worth over $13 Million. Details can be seen in Presidio Management Group Xii, L.l.c.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Presidio Management Group Xii, L.l.c. has not made any transactions after 2020-12-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Presidio Management Group Xii, L.l.c.
Presidio Management Group Xii, L.l.c. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Presidio Management Group Xii, L.l.c. owns 2 companies in total, including Silverback Therapeutics Inc (SBTX) , and ARS Pharmaceuticals Inc (SPRY) .
Insider Ownership Summary of Presidio Management Group Xii, L.l.c.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBTX | Silverback Therapeutics Inc | 2020-12-08 | 10 percent owner |
| SPRY | ARS Pharmaceuticals Inc | 2020-12-03 | 10 percent owner |
Presidio Management Group Xii, L.l.c. Latest Holdings Summary
Presidio Management Group Xii, L.l.c. currently owns a total of 1 stock. Presidio Management Group Xii, L.l.c. owns 2,221,798 shares of Silverback Therapeutics Inc (SBTX) as of December 8, 2020, with a value of $13 Million.
Latest Holdings of Presidio Management Group Xii, L.l.c.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SBTX | Silverback Therapeutics Inc | 2020-12-08 | 2,221,798 | 5.87 | 13,041,954 |
Holding Weightings of Presidio Management Group Xii, L.l.c.
Presidio Management Group Xii, L.l.c. Form 4 Trading Tracker
According to the SEC Form 4 filings, Presidio Management Group Xii, L.l.c. has made a total of 1 transactions in Silverback Therapeutics Inc (SBTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Silverback Therapeutics Inc is the acquisition of 47,619 shares on December 8, 2020, which cost Presidio Management Group Xii, L.l.c. around $999,999.
Insider Trading History of Presidio Management Group Xii, L.l.c.
- 1
Presidio Management Group Xii, L.l.c. Trading Performance
GuruFocus tracks the stock performance after each of Presidio Management Group Xii, L.l.c.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Presidio Management Group Xii, L.l.c. is 49.44%. GuruFocus also compares Presidio Management Group Xii, L.l.c.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Presidio Management Group Xii, L.l.c. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Presidio Management Group Xii, L.l.c.'s insider trading performs compared to the benchmark.
Performance of Presidio Management Group Xii, L.l.c.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 30.86 | | | | | |
| Relative Return to S&P 500(%) | 27.55 | | | | | |
Presidio Management Group Xii, L.l.c. Ownership Network
Presidio Management Group Xii, L.l.c. Owned Company Details
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
Presidio Management Group Xii, L.l.c. is the 10 percent owner of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and Chief Financial Officer Kathleen D. Scott .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
Presidio Management Group Xii, L.l.c. Mailing Address
Above is the net worth, insider trading, and ownership report for Presidio Management Group Xii, L.l.c.. You might contact Presidio Management Group Xii, L.l.c. via mailing address: 1460 El Camino Real, Suite 100, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
